ResearcherUniversity Hospital OlomoucNo recent work listed
Michael Fabian Nentwich
Matched on ORCID iD 0000-0001-7510-7230; OpenAlex author ID A5061851143. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers
Papers 9
- Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
- Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/carcin/bgab057↗
- Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. Co-author DOI 10.1136/jmedgenet-2020-106961↗
- Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
- Oligometastases in pancreatic cancer (Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic o… Last author DOI 10.1002/ags3.12255↗
- Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry. Co-author DOI 10.1002/jso.23826↗
- Limits of surgery for pancreatic cancer. Co-author PMID 25301342↗
- Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice. Co-author DOI 10.1136/gutjnl-2011-300629↗
- Surgery for advanced and metastatic pancreatic cancer--current state and trends. Co-author PMID 22593478↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jakob Robert Izbicki · 5 shared papers, 2012–2019 · strength 0.35
- Paper Oligometastases in pancreatic cancer (Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a … DOI 10.1002/ags3.12255↗
- Paper Limits of surgery for pancreatic cancer. PMID 25301342↗
- Paper Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and … DOI 10.1002/jso.23826↗
- Nina Voss · 1 shared paper, 2019 · strength 0.16
- Maximilian Bockhorn · 3 shared papers, 2012–2015 · strength 0.12
- Paper Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and … DOI 10.1002/jso.23826↗
- Paper Surgery for advanced and metastatic pancreatic cancer--current state and trends. PMID 22593478↗
- Paper Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in … DOI 10.1136/gutjnl-2011-300629↗
- Alexander T. El Gammal · 1 shared paper, 2015 · strength 0.05
- Kai A. Bachmann · 1 shared paper, 2015 · strength 0.05
- Oliver Mann · 1 shared paper, 2015 · strength 0.05
- Yogesh Kumar Vashist · 1 shared paper, 2015 · strength 0.05
- Güllü Cataldegirmen · 1 shared paper, 2012 · strength 0.04
- Florian Gebauer · 1 shared paper, 2013 · strength 0.03
- Daniel Wicklein · 1 shared paper, 2013 · strength 0.03
- Udo Schumacher · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.